Kayla St Amour
Gerontology · Griswold, CTNPI 1205330610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 331 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,806 and has fallen 97.5% since, to $70 in 2024. Among gerontology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 331 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$759
- GSK$379
- Merz North America, Inc.$298
- Merck$290
- AstraZeneca$288
- plus $3K from 34 others
What the payments were for
- Food & beverage$5,46696%
- Education$2084%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 52 | $1,011 |
| Novo Nordisk | 59 | $759 |
| GSK | 29 | $379 |
| Merz North America, Inc. | 4 | $298 |
| Merck | 17 | $290 |
| AstraZeneca | 16 | $288 |
| Amgen | 16 | $248 |
| Boehringer Ingelheim | 15 | $228 |
| Pfizer | 10 | $173 |
| Amarin Pharma, Inc. | 10 | $171 |
| Endo Pharmaceuticals Inc. | 7 | $150 |
| Eisai Inc. | 11 | $146 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $130 |
| Otsuka America Pharmaceutical, Inc. | 7 | $122 |
| Novartis | 5 | $119 |
| Sanofi-aventis U.S. LLC | 5 | $85 |
| Lilly USA, LLC | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Astellas Pharma US Inc | 4 | $75 |
| Sunovion Pharmaceuticals Inc. | 7 | $73 |
| Lundbeck LLC | 4 | $70 |
| Abbott | 4 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $64 |
| Neurocrine Biosciences, Inc. | 3 | $60 |
| Insulet Corporation | 3 | $59 |
| Johnson & Johnson | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| USWM, LLC | 3 | $52 |
| Currax Pharmaceuticals LLC | 3 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Medtronic | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Lifescan, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$116
How this compares
$5,674 in reported general payments places this provider in the 95th percentile of 90 gerontology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 23 | $206 |
| Levothyroxine Sodium | 15 | $146 |
| Losartan Potassium | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Griswold
- Amanda StrileckisSouthington$9K
- Gabriell BudoffOld Lyme$6K
- Jacqueline MurilloMiddlebury$5K
- Ryan MansiNorwich$5K
- Lauren SperingoVernon$4K
- Amber WachtarzBloomfield$4K
- Susan AdeShelton$3K
- Hannah DehertoghWest Hartford$3K
- Shannon KukulkaNew Haven$3K
- Melissa TuohyWallingford$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.